COVID-19 and tobacco cessation: lessons from India.
COVID-19
Cessation
India
Smoking
Tobacco
Journal
Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
12
08
2021
revised:
20
10
2021
accepted:
11
11
2021
pubmed:
22
12
2021
medline:
13
1
2022
entrez:
21
12
2021
Statut:
ppublish
Résumé
The Government of India prohibited the sale of tobacco products during the COVID-19 lockdown to prevent the spread of the SARS-CoV-2 virus. This study assessed the tobacco cessation behaviour and its predictors among adult tobacco users during the initial COVID-19 lockdown period in India. A cross-sectional study was conducted with 801 adult tobacco users (both smoking and smokeless tobacco) in two urban metropolitan cities of India over a 2-month period (July to August 2020). The study assessed complete tobacco cessation and quit attempts during the lockdown period. Logistic and negative binomial regression models were used to study the correlates of tobacco cessation and quit attempts, respectively. In total, 90 (11.3%) tobacco users reported that they had quit using tobacco after the COVID-19 lockdown period. Overall, a median of two quit attempts (interquartile range 0-6) was made by tobacco users. Participants with good knowledge on the harmful effects of tobacco use and COVID-19 were significantly more likely to quit tobacco use (odds ratio [OR] 2.2; 95% confidence interval [CI] 1.2-4.0) and reported more quit attempts (incidence risk ratio 5.7; 95% CI 2.8-11.8) compared to those with poor knowledge. Participants who had access to tobacco products were less likely to quit tobacco use compared to those who had no access (OR 0.3; 95% CI 0.2-0.5]. Access restrictions and correct knowledge on the harmful effects of tobacco use and COVID-19 can play an important role in creating a conducive environment for tobacco cessation among users.
Identifiants
pubmed: 34933205
pii: S0033-3506(21)00441-8
doi: 10.1016/j.puhe.2021.11.010
pmc: PMC8633921
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
93-99Subventions
Organisme : Medical Research Council
ID : MR/P027946/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P027946/2
Pays : United Kingdom
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Tob Use Insights. 2015 Jul 14;8:1-35
pubmed: 26242225
J Community Health. 2021 Jun;46(3):471-475
pubmed: 32643078
Tob Control. 2013 May;22 Suppl 1:i3-5
pubmed: 23591502
Nutrients. 2020 Jun 03;12(6):
pubmed: 32503173
Nicotine Tob Res. 2020 Aug 24;22(9):1662-1663
pubmed: 32343816
Indian J Med Ethics. 2021 Jan-Mar;VI(1):1-12
pubmed: 34080993
East Mediterr Health J. 2020 Jun 24;26(6):630-632
pubmed: 32621493
Tob Use Insights. 2020 Sep 25;13:1179173X20960447
pubmed: 33033429
Tob Induc Dis. 2020 Jul 27;18:63
pubmed: 32733178
Tob Control. 2020 May;29(Suppl 3):s216-s226
pubmed: 32321855
BMC Public Health. 2012 Aug 28;12:701
pubmed: 22928740
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656
pubmed: 32399563
Nicotine Tob Res. 2020 Aug 24;22(9):1671-1672
pubmed: 32459837
Tob Control. 2013 Jan;22(1):46-51
pubmed: 22535364
J Public Health Manag Pract. 2018 Sep/Oct;24(5):448-457
pubmed: 29346189
J Clin Epidemiol. 2003 Jun;56(6):559-64
pubmed: 12873651
Int J Ment Health Addict. 2023;21(2):1025-1040
pubmed: 34483782
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
Lancet Public Health. 2020 Nov;5(11):e577
pubmed: 33120038
Tob Prev Cessat. 2020 Sep 14;6:53
pubmed: 33083681
Environ Sci Pollut Res Int. 2021 Aug;28(30):40346-40354
pubmed: 33029777
Prev Med. 2018 Sep;114:102-106
pubmed: 29953897
Lancet Digit Health. 2020 Aug;2(8):e435-e440
pubmed: 32835201
Drug Alcohol Depend. 2013 Oct 1;132(3):479-85
pubmed: 23570817
Tob Induc Dis. 2020 May 06;18:39
pubmed: 32395100